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A complex of ExbB, ExbD, and TonB couples cytoplasmic membrane (CM) proton motive
force (pmf) to the active transport of large, scarce, or important nutrients across the outer
membrane (OM). TonB interacts with OM transporters to enable ligand transport. Several
mechanical models and a shuttle model explain howTonB might work. In the mechanical
models, TonB remains attached to the CM during energy transduction, while in the shut-
tle model the TonB N terminus leaves the CM to deliver conformationally stored potential
energy to OM transporters. Previous studies suggested thatTonB did not shuttle based on
the activity of a GFP–TonB fusion that was anchored in the CMby theGFPmoiety.Whenwe
recreated the GFP–TonB fusion to extend those studies, in our hands it was proteolytically
unstable, giving rise to potentially shuttleable degradation products. Recently, we discov-
ered that a fusion of the Vibrio cholerae ToxR cytoplasmic domain to the N terminus of
TonB was proteolytically stable.ToxR–TonB was able to be completely converted into a pro-
teinase K-resistant conformation in response to loss of pmf in spheroplasts and exhibited
an ability to form a pmf-dependent formaldehyde crosslink to ExbD, both indicators of its
location in the CM. Most importantly, ToxR–TonB had the same relative speciﬁc activity as
wild-type TonB. Taken together, these results provide conclusive evidence that TonB does
not shuttle during energy transduction. We had previously concluded that TonB shuttles
based on the use of an Oregon Green® 488 maleimide probe to assess periplasmic acces-
sibility of N-terminal TonB. Here we show that the probe was permeant to the CM, thus
permitting the labeling of the TonB N-terminus. These former results are reinterpreted in
the context thatTonB does not shuttle, and suggest the existence of a signal transduction
pathway from OM to cytoplasm.
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INTRODUCTION
The TonB system energizes the transport of large, scarce, and
important nutrients such as vitamin B12 and siderophores com-
plexed with iron across the outer membrane (OM) of Escherichia
coli. A complex of the cytoplasmic membrane (CM) proteins
ExbB and ExbD harnesses energy derived from the proton
motive force (pmf) and transmits this energy to TonB. TonB
then physically contacts a ligand-loaded TonB-gated transporter
(TGT) in the OM, thus enabling release of the ligand into
the periplasmic space. The per-cell copy number ratio of the
TonB:ExbB:ExbD proteins is 1:7:2, although the precise ratio in
an energy-transducing complex is unknown (Higgs et al., 2002).
In E. coli, one set of tonB–exbB–exbD genes supports transport for
multiple TGTs. But in certain other species, logistics are more
complex; for example, Xanthomonas campestris has eight tonB
genes and genes for 48 different transporters (Schauer et al.,
2008).
Escherichia coli TonB has a topology consistent with that of
an inter-membrane energy transducer: a short cytoplasmic region
(residues 1–11), an N-terminal transmembrane domain (TMD,
residues 12–32), a periplasmic linker region from 33–149, and a
C terminus (residues 150–239) capable of interacting with TGTs.
The TMD is essential for localization andmaintaining interactions
with integral CM proteins ExbB/D (Karlsson et al., 1993; Larsen
et al., 1999; Ollis et al., 2009). The periplasmic linker domain is
predicted to be largely disordered and contains a non-essential
proline-rich domain from 70–102 (Larsen et al., 1993, 2007; Pea-
cock et al., 2005). The C terminus is essential for interaction
with TGTs, but none of the 90 residues in the C terminus are
individually essential for function (Postle et al., 2010). The mol-
ecular mechanism by which TonB transduces energy from the
CM to TGTs and facilitates subsequent ligand transport is largely
unknown.
The question of how TonB participates in energy transduction
has been fertile ground for researchers’ imaginations since the idea
of energy transduction from the CM pmf to the OM ﬁrst emerged
(Hancock and Braun, 1976). In 1980, the Bradbeer laboratory
suggested the possibility that TonBmight synthesize amobilemes-
senger that would diffuse from CM to OM (Reynolds et al., 1980).
Wookey (1982) proposed that TonBmight be a periplasmic perme-
ase. Kadner (1990) proposed the idea that TonB might shuttle in
a review article. Subsequent evidence for the shuttle model came
from sucrose density gradient fractionation experiments where
our lab showed TonB to localize in a CM:OM ratio of 60:40%, and
exclusively at the OM in conditions in which ExbB/D and TolQ/R
were absent (Letain and Postle, 1997). These initial ﬁndings were
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supported by in vivo demonstrations that a cys substitution in
the extreme TonB N terminus, L3C, could be labeled with the
probe Oregon Green® 488 maleimide (OGM; Larsen et al., 2003).
As a control, truncated TonB L3C, consisting of the N-terminal
168 amino acids, was unable to interact with TGTs and could
not be labeled although it formed a normal complex with ExbB.
The degree of labeling for TonB L3C also increased substantially
in the absence of the CM proteins ExbB/D and TolQ/R. Taken
together, the results suggested that the extreme N terminus of
TonB was labeled in the periplasm after it had departed from the
CM. We suggested that energy transduction involved the physical
cycling between the CM and OM compartments, a process called
“shuttling.”
Alternative models have arisen since that time, including a pro-
pellermodel, a pullingmodel, and a PBP-assistedmodel (reviewed
in Krewulak andVogel, 2011).What the later models have in com-
mon is that the TonB TMDnever leaves the CMwhile accomplish-
ing its functions. None of the models for TonB-dependent energy
transduction has been widely embraced or ruled out, because of a
lack of conclusive supporting evidence.
Here we show that in our hands a GFP–TonB fusion was too
proteolytically unstable to allow meaningful interpretation of the
data. In contrast, a fusion of the cytoplasmic domain of Vibrio
cholerae ToxR (aa 1–181) to the N terminus of TonB was pro-
teolytically stable, localized to the CM and had a relative speciﬁc
activity that was essentially the same as wild-type TonB. These data
indicated that TonB does not shuttle. We also discovered that our
previous interpretation that TonB shuttled had been compromised
by the fact, shown in these studies, that OGM could leak across
the CM and label a cys substitution in a cytoplasmically conﬁned
TonB derivative. In light of these ﬁndings, our previous data are
reinterpreted here.
MATERIALS AND METHODS
MEDIA, CULTURE CONDITIONS
Saturated overnight cultures grown in Luria-Bertani (LB) broth
were subcultured 1:100 into M9 minimal medium or MOPS
medium with chloramphenicol added to 34μg/ml as necessary to
maintain plasmids (Shedlovsky and Brenner, 1963; Miller, 1972;
Neidhardt et al., 1974). For M9 minimal medium, M9 salts were
supplemented with 0.5% glycerol, 0.2% casamino acids (wt/vol),
40μg/ml tryptophan, 0.4μg/ml thiamine, 1mM MgSO4, 0.5mM
CaCl2, and 1.85μM FeCl3 (Postle, 2007). When necessary, l-
arabinose or sodiumpropionatewas added to induce expression of
the TonB derivatives to normal chromosomal levels. For all assays,
cells were grown to mid-exponential phase of 0.4–0.5A550 units
as measured on a Spectronic 20 spectrophotometer using a 1.5 cm
pathway. A sample of each culture was precipitated with an equal
volume of ice cold 20% w/v trichloro acetic acid (TCA) and pro-
tein levelswere visualizedon immunoblots of SDS-polyacrylamide
gels.
STRAINS AND CONSTRUCTION OF PLASMIDS
Escherichia coli K-12 strains W3110 [F− IN(rrnD–rrnE)1; Hill
and Harnish, 1981)], KP1344 (W3110 ΔtonB::blaM ; Larsen et al.,
1999), KP1440 (W3110 ΔtonB::blaM exbB::Tn10, tolQam; Larsen
et al., 2003), KP1035 (W3110 entA::mini-kan), KP1229 (W3110
Δ ana–tonB–trpC ; Ahmer et al., 1995), and KP1231 [W3110
Δ(ana–tonB–trpC) entA::mini-kan] were the principal strains
used in this study. KP1231 was constructed by sequential P1vir
transduction of the entA::mini-kan cassette from MK3, a gener-
ous gift fromMarkMcIntosh, intoW3110 to generate KP1035 and
ﬁnally from KP1035 into KP1229 to yield KP1231 (Ahmer et al.,
1995). Plasmids used in this study are shown in Table 1. Attempts
weremade to replicate construction of a GFP–TonB fusion protein
previously described (Kaserer et al., 2008), where sggfp is con-
nected to tonB by a BamHI site. The plasmid encoding the exact
GFP variant (sggfp) used in that studywas no longer available (dis-
continued by the manufacturer), so a gfpmut2 variant was used
(encoded on pDR107B, a generous gift from P. de Boer). sggfp
and gfpmut2 both encode derivatives of Aequorea victoria green
ﬂuorescent protein. Each has three substitutions to increase or
enhance GFP ﬂuorescence, but the substitutions are different –
for sggfp, F64L, S65C, and I167T (Kaserer et al., 2008) and for
gfpmut2, S65A, V68L, and S72A (Cormack et al., 1996) gfpmut2–
tonB was constructed in three steps. First, tonB including the native
RBS, from pKP325, was cloned into pPro33 using a 5′ KpnI site
and 3′ SphI site, creating pKP1141 (primer sequences available
upon request). Digestion of pPro33with these restriction enzymes
excised the unique BamHI site in the pPro33 MCS, since a unique
BamHI site was needed in the ﬁnal construct, as described above.
In the second step, a BamHI site was added immediately before
the tonB start codon in pKP1141, creating pKP1159. Forward and
reverse primers were designed with the desired insertion ﬂanked
onboth sides by 12–15homologousbases.DpnI digestionwasused
to remove the template plasmid. Cloneswere screened for the pres-
ence of the BamHI site. In the third step, gfpmut2 from pDR107B
was ampliﬁed, from the start codon through the ﬁnal codon
for Lys238 (no stop codon) and introducing ﬂanking BamHI
Table 1 | Plasmids used in this study.
Plasmid name Relevant genotype/
phenotype
Reference
pDR107B pET21B derivative encoding
GFP mut 2-T7tag-his fusion
protein; Ampr
Raskin and De Boer
(1997)
pBAD33 PBAD promoter; AraC; Camr Guzman et al. (1995)
pPro33 pBAD33 2-methyl-citrate
inducible; Camr
Lee and Keasling
(2005)
pASAToxRTonB1 pHK toxR(1–181) –
tonB(1–239) Camr
Sauter et al. (2003)
pKP325 TonB (araBAD regulated);
AraC Camr
Larsen et al. (1999)
pKP477 pKP325 ΔTonB Ghosh and Postle
(2004)
pKP478 pKP325TonB L3C C18G Larsen et al. (2003)
pKP544 pKP325TonB L3C ΔTMD This study
pKP1141 pPro33 tonB This study
pKP1159 pPro33 tonB with novel
BamHI site
This study
pKP1160 pPro33 gfpmut2–tonB This study
pKP1529 pBAD33ToxR–TonB This study
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sites. This was cloned into the BamHI site of pKP1159, creating
pKP1160 (gfpmut2–tonB). Clones were screened for insert orien-
tation with with NcoI. With the exception of the GFP modiﬁca-
tions, this constructwas the sameaspGT fromKaserer et al. (2008).
Plasmid pKP1529 was generated by cloning PCR-ampliﬁed
ToxR–TonB (including the ToxR Shine–Dalgarno sequences) from
pASAToxRTonB1 (Sauter et al., 2003) into the unique XbaI site in
pBAD33 (Guzman et al., 1995). As a result, ToxR–TonB expression
was now regulated by the PBAD promoter. All other plasmids are
derivatives of pKP325 (Larsen et al., 2007). Plasmid pKP544 was
constructed by extra-long PCR, resulting in the removal of TonB
residues 13–35. Plasmid DNA sequences were veriﬁed at the Penn
State Genomics Core Facility – University Park, PA, USA.
IN VIVO FORMALDEHYDE CROSSLINKING
Formaldehyde crosslinking assays were performed essentially as
described previously (Postle, 2007; Ollis et al., 2009). Mid-
exponential phase cells were resuspended in sodium phosphate
buffer pH 6.8. A portion of each culture served as a control for
TonB expression levels. To examine crosslinking of ToxR–TonB in
the absence of pmf, carbonylcyanide-m-chlorophenylhydrazone
(CCCP) was added to a ﬁnal concentration of 50μM.As a control
for solvent addition, dimethyl sulfoxide (DMSO) was added to
each sample that was not treated with CCCP. Samples were incu-
bated at 37˚C for 5min. and treated with 16% paraformaldehyde
(ﬁnal concentration 1%) for 15min at room temperature. After
centrifugation for 5min at room temperature, crosslinked sam-
ples were solubilized in sample buffer (Laemmli, 1970) at 60˚C for
5min., and uncrosslinked samples were boiled at 95˚C for 7min.
Complexes were visualized on immunoblots with the anti-TonB
monoclonal (4F1) and anti-ExbD polyclonal antibodies (Larsen
et al., 1996; Higgs et al., 2002).
[55Fe]FERRICHROME TRANSPORT
Mid-exponential phase cells were harvested, suspended in buffer
and initial rates of [55Fe]ferrichrome transport were determined
in triplicate as described (Postle, 2007). A sample of each culture
was TCA precipitated immediately prior to assay to determine
TonB expression levels. Proteins were visualized on immunoblots
of SDS-polyacrylamide gels with the anti-TonB monoclonal anti-
body 4F1. This experiment was performed independently three
times and the same results obtained.
PROTEINASE K ACCESSIBILITY
Strains expressing TonB derivatives were converted to either intact
or lysed spheroplasts andwere treatedwithorwithout proteinaseK
and with or without carbonylcyanide-m-chlorophenylhydrazone
(CCCP) as described previously (Larsen et al., 1999). Proteinase
K-resistant forms were visualized on immunoblots with the
monoclonal antibody 4F1.
ELECTRON MICROSCOPY PREPARATIONS
Plasmid-bearing mid-exponential phase KP1344 cells were pel-
leted and ﬁxed with glutaraldehyde and paraformaldehyde at
concentrations of 2% w/v, each according to standard protocols
from the Franceschi Microscopy and Imaging Center, Washing-
ton State University, Pullman,WA,USA. Samples were dehydrated
in an ethanol series and then embedded in LR-White resin. Cured
samples were thin sectioned and adhered to nickel grids. Immuno-
labeling was performed with 1:100 4F1, followed by 1:100 goat
anti-mouse antibody conjugated with 20 nm gold particles. Grids
were stained with uranyl acetate and lead citrate and visualized
with a JEOL transmission electron microscope (JEOL USA Inc.)
with images captured with a MegaViewIII Digital camera at the
Franceschi Microscopy and Imaging Center.
OREGON GREEN® MALEIMIDE LABELING
In vivo labeling was performed as described previously (Larsen
et al., 2003). Brieﬂy, 75ml cells were grown in LB broth with
34μg/ml chloramphenicol to an A550 of 0.50. Buffer A (50mM
KPO4, 100mM K2SO4, pH 7.0) was added to 25ml of cells and
OGM in DMSO was added to a ﬁnal concentration of 172μM.
Samples were incubated for 1 h on ice with shaking and were
quenched with 2-mercapoethanol. After washing three times with
Buffer A, samples were suspended in Tris–LSB, boiled for 10min
and frozen at −30˚C.
In vitro labeling was performed in a manner similar to the
in vivo labeling protocol but differed in that RIPA buffer (1% Tri-
ton X-100, 1% sodium deoxycholate, 1% SDS in 150mM NaCl
50mM Tris-acetate pH 7.6) was added to harvested cells, the cells
were passed twice through a French Pressure cell, and lysate was
collected. Samples were incubated with OGM and frozen as above
except that no LSB–Tris was added prior to freezing. The results
did not change for either in vivo or in vitro labeling regardless
of whether or not 2-mercaptoethanol was added to quench the
reaction.
IMMUNOPRECIPITATION
In vivo and in vitro samples were thawed, and TonB was immuno-
precipitated with a cocktail of 4F1 and 4H4 monoclonal antibody
as described previously (Larsen et al., 2003). Samples for GroEL
analysis were prepared the same way as the TonB samples but
immunoprecipitated with anti-GroEL antibody (Stressgen Biore-
agents, Victoria, BC, Canada). Samples were divided, resolved
on SDS-polyacrylamide gels and immunoblots were subsequently
developed with either anti-TonB or anti-GroEL antibodies and
anti-OGM (Pierce) antibodies.
RESULTS
GFP–TonB CAN GIVE RISE TO “SHUTTLEABLE” DEGRADATION
PRODUCTS
A recent study fused GFP from A. victoria to the N terminus
of TonB and asked whether or not this GFP–TonB construct
was active (Kaserer et al., 2008). The fusion of the TonB cyto-
plasmic N terminus to a large cytoplasmically localized protein
should prevent potential shuttling by keeping TonB retained in
the CM. The GFP–TonB construct supported TonB activity and
the authors concluded that TonB did not shuttle. To extend this
work, we reconstructed a GFP–TonB fusion with the same linker
sequence between GFP and TonB as was used in that study and
used TCA to precipitate bacteria immediately upon harvest to pre-
vent the degradation of GFP–TonB (and presumably GFP–TonB
fragments) that could occur in gel sample buffer at 95˚C (Skare
and Postle, 1991). This allowed for accurate determination of the
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steady-state levels of all TonB-speciﬁc peptides. In our hands,
expression of GFP–TonB at chromosomal levels resulted in the
detection of several prominent degradation products (Figure 1).
The results did not change regardless of whether M9 or MOPS
medium was used, nor if GFP–TonB was expressed in the tonB
entA strain KP1231 (data not shown). The degradation products
that were the size of full-length TonB or slightly larger might sup-
port TonB activity by shuttling. Because of the challenges and
problems with proteolysis and because the mechanism of TonB
energy transduction is still considered an open question (Krewu-
lak and Vogel, 2011), we wanted to identify a system that could
answer the question of shuttling more deﬁnitely.
ToxR (1–181) – TonB IS STABLE AND FULLY ACTIVE
During the course of studies on TonB dimerization, we identiﬁed
a fusion of full-length TonB to the cytoplasmic domain (aa 1–181)
of V. cholerae ToxR (Miller et al., 1987), that was extremely stable
as expressed from pASAToxRTonB1 and analyzed by immunoblot
(data not shown). This plasmid was a kind gift of V. Braun from
earlier studies on TonB dimerization where the expression lev-
els and activities of the ToxR–TonB constructs were not reported
(Sauter et al., 2003). Because ToxR–TonB was overexpressed from
pASAToxRTonB1 (data not shown), we cloned toxR–tonB, includ-
ing its putative Shine–Dalgarno sequences into pBAD33 so that
its expression could be regulated by the PBAD promoter (Guzman
et al., 1995).
Like wild-type TonB, virtually all of the ToxR–TonB could be
converted into a proteinase K-resistant conformation by collapse
of the pmf due to CCCP addition (Figure 2). Because ExbB and
ExbD are required for this proteinase K-resistant conformation
FIGURE 1 | GFP–TonB exhibits prominent degradation in vivo.
Steady-state levels were determined as described in Section “Materials
and Methods” with the following strains: cTonB (W3110 expressing
chromosomally encodedTonB); ΔTonB (KP1344); pPro33-TonB
(KP1344/pKP1159); and pPro33 GFP–TonB (KP1344/pKP1160). Sodium
propionate (*) was added to induce expression of plasmid-encodedTonB or
GFP–TonB as follows: 0, 1, 5, 10mM.TonB expression levels were
visualized on immunoblots of 11% SDS-polyacrylamide gels with theTonB
monoclonal antibody 4F1. Mass standards (kDa) are shown on the left.
Full-length TonB migrates at 36 kDa, and the position of full-length
GFP–TonB is indicated by the arrow.The most likely proteins to serve as the
source of activity if TonB shuttles are indicated by the bracket.
(Larsen et al., 1999), it suggested thatToxR–TonBwas located in the
CM. The pmf is also required for TonB and ExbD to formaldehyde
crosslink in vivo through their periplasmic domains (Ollis et al.,
2009). Likewise,ToxR–TonBwas also able to form this functionally
signiﬁcant crosslink with ExbD (Figure 3), and this complex was
undetectedwhen pmf was collapsedwithCCCP. Thus,ToxR–TonB
could be energized in the same way as wild-type TonB.
Finally, [55Fe]ferrichrome transport assays revealed that ToxR–
TonB, when expressed to chromosomal levels, supported ∼100%
of the wild-type plasmid-encoded TonB ferrichrome transport
rate (Figure 4). ToxR–TonB supported 84 and 92% of wild-type
activity in additional triplicate trials (data not shown). The key
observation was that this activity could only have arisen from full-
length ToxR–TonB. The amount of TonB in the uninduced sample
(pTonB no ara) far exceeded the amount of the only detectable
degradation product that derived fromToxR–TonB and supported
only 12% activity (Figure 4). Thus, stable, full length ToxR–TonB
had the same relative speciﬁc activity as chromosomally encoded
wild-type TonB.
MEMBRANE PERMEABILITY OF OGM EXPLAINS PREVIOUS RESULTS
The strongest prior evidence for in vivo shuttling was the demon-
stration that a cys substitution predicted to be cytoplasmically
localized could be labeled by OGM in full-length TonB but not in
a truncated TonB derivative missing much of its C terminus and
incapable of interaction with the OM (Larsen et al., 2003). OGM
has been considered a “generally membrane impermeant” probe,
and other groups have used this reagent to discriminate between
free cysteines in the periplasmor cytoplasmof Gram-negative bac-
teria (Ye et al., 2001; Ye and Maloney, 2002; Yang et al., 2005; Liu
et al., 2007; Nanatani et al., 2007, 2009). Given the contrast in ﬁnd-
ings between the ToxR fusions and the OGM labeling, we tested
the possibility that OGM leakage across the CM could account for
our previous ﬁndings (Larsen et al., 2003).
To assess the potential for OGM to leak across the CM,we con-
structed a TonB variant lacking its transmembrane domain but
FIGURE 2 |ToxR–TonB is conformationally responsive to pmf. Strains
were converted to spheroplasts and treated with or without proteinase K
and CCCP as described in Section “Materials and Methods” with the
following strains: cTonB (W3110 expressing chromosomally encodedTonB)
and pToxR–TonB [KP1344 (ΔtonB)/pKP1529]. L-Arabinose was added to
induce expression of ToxR–TonB to chromosomal levels (0.00046%).
Samples were resolved on 13% SDS-polyacrylamide gels, and
immunoblotting was performed with the α-TonB monoclonal antibody 4F1.
Mass standards are shown on the left. Abbreviations:WC, whole cells; Sph,
spheroplasts; PKRF, proteinase K-resistant fragment.
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FIGURE 3 |ToxR–TonB makes the pmf-dependent crosslink with ExbD.
Crosslinking was performed as described in Section “Materials and
Methods” with the following strains: cTonB (W3110 expressing
chromosomally encodedTonB and ExbD); ΔTonB (KP1344); pTonB
(KP1344/pKP325); pToxR–TonB (KP1344/pKP1529); and pToxR–TonB CCCP
(KP1344/pKP1529 treated with 50μM CCCP). L-Arabinose was added to
induce expression of plasmid-encodedTonB as follows: 0.00075% for
pTonB and 0.00046% for pToxR–TonB. Complexes were detected on
immunoblots of 13% SDS-polyacrylamide gels using ExbD polyclonal
antibodies (upper two panels). Uncrosslinked monomeric TonB and
ToxR-TonB levels were visualized with the monoclonal anti-TonB antibody
4F1 (bottom panel). The molecular mass standards (kDa) are shown on
the left.
retaining the L3C substitution of the original OGM labeling study.
TonB L3C ΔTMD expressed from pKP544 should be cytoplasmi-
cally localized (Karlsson et al., 1993). The cytoplasmic localization
of the TonB L3C ΔTMD construct was tested by two meth-
ods: proteinase K accessibility assays in intact spheroplasts and
transmission electron microscopy immunolocalization. Whereas
wild-type TonB (TonB L3C C18G) is sensitive to proteinase K in
intact spheroplasts, the TonB L3C ΔTMD was sequestered from
proteinase K (Figure 5A). When spheroplasts were lysed, both
TonB L3C C18G and TonB L3C ΔTMD were sensitive to pro-
teinase K, indicating that TonB L3C ΔTMD was cytoplasmically
localized (Figure 5A). The same results were also obtained in
FIGURE 4 |ToxR–TonB supports as much activity as plasmid-encoded
wild-typeTonB. Ferrichrome transport assays were performed as
described in Section “Materials and Methods” with the following strains:
cTonB (W3110 expressing chromosomally encodedTonB); ΔTonB (KP1344);
pTonB (KP1344/pKP325); pTonB no ara (KP1344/pKP325 uninduced); and
pToxR–TonB (KP1344/pKP1529). L-Arabinose was added to induce
expression of plasmid-encodedTonB as follows: 0.00075% for pTonB and
0.00045% for pToxR–TonB. Initial ferrichrome transport rates are as follows,
expressed as counts per minute (cpm)/0.05 A550 ml cells/minute: cTonB
453±31; pTonB 326±13 (standard to 100%); pTonB no ara 39±7 (12%);
pToxR–TonB 333±15 (102%); ΔTonB −4±4 (0%). TonB expression levels
were visualized on immunoblots of 11% SDS-polyacrylamide gels with
anti-TonB monoclonal antibody 4F1. A longer exposure is shown to provide
a comparison between uninduced pKP325 and the lack of full-length
degradation product from pKP1529. Mass standards are shown on the
right. Degradation products are marked with an asterisk (*).
KP1344 (data not shown). Consistent with that result, electron
microscopy revealed that the TonB L3C ΔTMD was conﬁned to
the cytoplasm whereas gold particles detecting wild-type TonB
localized to the envelope (Figure 5B).
Oregon Green® 488 maleimide was able to label the cytoplas-
mically localized TonB L3C ΔTMD both in vitro and in vivo. This
showed that in our previous experiments, OGM was indeed capa-
ble of crossing the CM and TonB L3C did not need to shuttle to
become labeled by it (Figure 6). In addition, OGM labeled the
cytoplasmic chaperone GroEL in vitro and in vivo, conﬁrming its
ability to leak across the CM (Figure 6).
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FIGURE 5 |TonB L3C ΔTMD is cytoplasmically localized. (A)TonB L3C
ΔTMD is resistant to proteinase K in intact spheroplasts but sensitive to
proteinase K in lysed spheroplasts. Strains pTonB L3C ΔTMD (KP1440
(ΔtonB, exbB::Tn10, tolQam)/pKP544) and pTonB L3C C18G
(KP1440/pKP478) were converted to either intact or lysed spheroplasts and
treated with or without proteinase K as described in Section “Materials and
Methods.” Proteins were resolved on 11% SDS-polyacrylamide gels and
immunoblotted with anti-TonB 4F1 antibodies. Abbreviations:WC, whole
cells; Sph, spheroplast; Lys, lysed spheroplast. (B) Electron micrographs of
strains cTonB (W3110 expressing chromosomally encodedTonB) or pTonB
L3C ΔTMD (KP1344/pKP544). Cells were ﬁxed and labeled with
immunogold particles as described in Section “Materials and Methods.”
Examples of labeledTonB derivatives are indicated with arrows. Size bars
are included at the bottom.
FIGURE 6 | Oregon Green maleimide labels cytoplasmic proteins. OGM
labeling and subsequent immunoprecipitation were performed as
described in Section “Materials and Methods” with the following strains:
cGroEL (W3110 expressing chromosomally encoded GroEL) and pTonB L3C
ΔTMD (KP1344/pKP544). Samples of cells were also lysed by passage
through a French pressure cell and labeled in vitro; these served as a
standard for 100% labeling. L-Arabinose was added to induce expression of
TonB L3C ΔTMD (0.002%). Proteins were also harvested by treatment with
TCA to serve as a total protein control. Samples were divided and resolved
on 11% SDS-polyacrylamide gels and immunoblotted with anti-TonB or
anti-GroEL antibodies for half of the samples and with anti-OGM antibodies
for the other half. Positions of TonB L3C ΔTMD and GroEL are indicated.
Molecular mass standards are shown in the center. Abbreviation: IP,
immunoprecipitation.
DISCUSSION
The fate of the TonB N terminus during energy transduction has
been speculated about and investigated for many years. Today, the
primary models that explain its role include several mechanical
models where TonB remains continuously associated with the CM
and the shuttle model, where TonB cyclically dissociates from the
CM and shuttles to the OM. Themechanical models suggest direct
use of the pmf in energizing TGTs with TonB as a bridge between
the two. The shuttle model suggests that TonB somehow stores
potential energy from the pmf prior to shuttling to the OM. The
TonB TMD was proposed to store the potential energy through
response of residues S16 and H20 to the pmf (Larsen and Postle,
2001). Because these two models have different consequences and
make different predictions, it is important to determine which is
correct.
Since the emergence of the shuttle model, we have learned that
the TonB TMD is highly tolerant to mutation. In particular, the
only sidechain that cannot be replaced by ala and retain activity
is H20, yet H20 can be replaced by asn and retain full activity,
suggesting that the TonB TMD is not on a proton translocation
pathway (Larsen et al., 2007; Swayne and Postle, 2011). These
results cast doubt on the shuttle hypothesis by eliminating the
TMD as the region of TonB that needed to be delivered to the
OM. Here we demonstrate that, in contrast to GFP–TonB, a fusion
of the cytoplasmic domain of ToxR (1–181) to TonB produced
virtually no degradation products when expressed at levels char-
acteristic of native TonB. ToxR–TonB appeared to be anchored in
the CM at all times because it could be fully converted to a pro-
teinase K-resistant form in de-energized cells. ToxR–TonB could
also form a pmf-dependent crosslink with ExbD and was fully
active in ferrichrome transport assays. This eliminated the possi-
bility that somehow the entire ∼180 residue folded cytoplasmic
domain of ToxR could be pulled out of the CM to shuttle. Even
if the ToxR domain could be pulled out of the CM, it would not
be possible for it to recross back into the cytoplasm and allow the
TonB portion to assume its rightful relationship with ExbB and
ExbD such that it had 100% activity. Because ToxR–TonB had an
equivalent relative speciﬁc activity to TonB,we conclude that TonB
does not shuttle. These results conﬁrmand expand the conclusions
of Kaserer et al. (2008).
The permeability of OGM to the CM explained the apparent
contradiction between the ToxR–TonB results, and the previous
ones suggesting that TonB shuttles in vivo (Larsen et al., 2003).
The data from our 2003 study can be reinterpreted in the light
of this new information. The labeling seen for full-length TonB
L3C can be explained by the observation that OGM diffuses into
the cytoplasm. A more interesting explanation may pertain to the
observation that TonBam168 L3C did not become labeled with
OGM, even though it still retained the ability to respond con-
formationally to pmf in spheroplasts and formaldehyde crosslink
to ExbB, indicating that the truncation did not radically inter-
fere with assembly with ExbB/D. The reinterpretation of the data
raises the question of whether there is signal transduction occur-
ring from the OM to the CM ExbB/D complex through TonB. It
could be that when full-length TonB is present, the cytoplasmic
domains of ExbB allow access of OGM to the extreme N terminus
of TonB. In this model, when the C terminus of TonB is deleted
and TonB does not associate with the OM, then the cytoplasmic
domains of ExbB are conformationally rearranged such that the
TonB L3C residue is sequestered. Consistent with that idea, TonB
Frontiers in Microbiology | Microbial Physiology and Metabolism October 2011 | Volume 2 | Article 206 | 6
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FIGURE 7 |TonB cannot reach OM transporters with the conformation
depicted by crystal structures of its C terminus.TonB residues 33–69
and 103–149, predicted to be disordered regions (Larsen et al., 2007), are
depicted as yellow rectangles. The span of the periplasmic space was
estimated based on crystal structure reconstructions of the AcrA/B/TolC
complex (Symmons et al., 2009). Abbreviations: CM, cytoplasmic
membrane; OM, outer membrane.
L3C was not labeled by OGM in the inside-out vesicles arising
from French-pressed cells that not only lacked pmf but also any
connection to the OM (data not shown).
The observation that TonB remains attached to the CM dur-
ing energy transduction has ramiﬁcations for the meaning of the
solved TonB–FhuA and TonB–BtuB crystal structures (Pawelek
et al., 2006; Shultis et al., 2006). The conformation of the TonB C
terminal domain solved in complex with the TGTs accounts only
for ∼25Å, but arises from ∼1/3 of the length of TonB (residues
153–233,with 239 being the terminal residue; Figure 7).While the
proline-rich domain can span up to 100Å of periplasmic space,
it is non-essential (Evans et al., 1986; Larsen et al., 1993; Seliger
et al., 2001). Based on the assembled structure of the periplasmic-
spanning AcrAB/TolC complex, the distance between the CM and
OM appears to be approximately 180Å (Symmons et al., 2009).
This suggests that the C terminus of TonB must be more dis-
ordered than is represented by the solved structures as it spans
the periplasm and identiﬁes a ligand-loaded transporter. Consis-
tent with that, the TonB primary amino acid sequence predicts a
highly disordered protein, and the C terminus is conformationally
dynamic in vivo (Larsen et al., 1999, 2007; Postle et al., 2010). If
TonB must be disordered in order to span the periplasm, then it is
likely that TonB C terminus participates in an energy transduction
cycle of association and dissociation from the TGTs rather than
being constantly associated with the OM. In support of this idea,
the number of OM transporters in a given cell exceeds the number
of available TonB molecules (Kadner and Heller, 1995; Higgs et al.,
2002; Postle et al., 2010).
In a detailed analysis of four TGT structures, Chimento et al.
(2005) noted that the β-strands of the cork domain that ﬁlls the
TGT barrel are mostly parallel to the periplasmic space. They pro-
pose that only a modest perpendicular force supplied by TonB
would be necessary to unfold the cork (Chimento et al., 2005).
Now that we know that TonB does not shuttle, and that it may
contact the TGT in a disordered conformation, it suggests that the
mere folding of TonB upon contact might be sufﬁcient to allow
transport.
These new data also raised the question of what the 30–40%
of TonB that fractionates with the OM represents. It could possi-
bly represent the fraction of TonB that is strongly associated with
the OM transporters at any one point in the energy transduction
cycle. Alternatively it could represent TonB that has temporarily
dissociated from the ExbB/D complex while its C terminus is asso-
ciated with the OM. In either case, it mustmean that TonB is being
artifactually pulled out of the CM because ExbB and ExbD remain
associated with the CM (Letain and Postle, 1997).
A remaining mystery is why, in the absence of ExbB/D and
TolQ/R, nearly all of the TonB is found associated with the OM.
It could be that the conformation of the TonB C terminus is such
that its default interaction is at the OM. Alternatively it may be
that the action of ExbB/D is primarily required to assist the TonB
C terminus in dissociating from anOM transporter after an energy
transduction event. The demonstration that TonB does not shuttle
eliminates debate concerning how energy would be used to phys-
ically remove TonB from a CM complex of ExbB/D, and also how
the N terminus would somehow target TonB back to an ExbB/D
complex at the CM (Larsen et al., 2003; Postle and Kadner, 2003).
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